Published in Am J Gastroenterol on September 13, 2011
The association between metabolic syndrome and colorectal neoplasm: systemic review and meta-analysis. J Clin Gastroenterol (2013) 2.21
Insulin resistance and cancer risk: an overview of the pathogenetic mechanisms. Exp Diabetes Res (2012) 1.55
New insights into pancreatic cancer-induced paraneoplastic diabetes. Nat Rev Gastroenterol Hepatol (2013) 1.54
Colorectal cancer screening and prevention in women. Dig Dis Sci (2015) 1.46
Diabetes and cause-specific mortality in a prospective cohort of one million U.S. adults. Diabetes Care (2012) 1.42
Predictors of Adherence to Multiple Clinical Preventive Recommendations among Adults with Diabetes in Spain. PLoS One (2015) 1.40
Is there a role for carbohydrate restriction in the treatment and prevention of cancer? Nutr Metab (Lond) (2011) 1.35
Tumor macroenvironment and metabolism. Semin Oncol (2014) 1.01
Risk factors for serrated polyps of the colorectum. Dig Dis Sci (2014) 0.96
Risk of bladder cancer in patients with diabetes mellitus: an updated meta-analysis of 36 observational studies. BMC Cancer (2013) 0.94
Somatic gene mutations in African Americans may predict worse outcomes in colorectal cancer. Cancer Biomark (2013) 0.94
A twenty-first century cancer epidemic caused by obesity: the involvement of insulin, diabetes, and insulin-like growth factors. Int J Endocrinol (2013) 0.93
Diabetes mellitus and risk of bladder cancer: a meta-analysis of cohort studies. PLoS One (2013) 0.93
The association of type and number of chronic diseases with breast, cervical, and colorectal cancer screening. J Am Board Fam Med (2014) 0.93
Impact of diabetes on oncologic outcome of colorectal cancer patients: colon vs. rectal cancer. PLoS One (2013) 0.90
Diabetes mellitus and risk of bladder cancer: a meta-analysis of cohort studies. PLoS One (2013) 0.89
Increased cancer incidence risk in type 2 diabetes mellitus: results from a cohort study in Tyrol/Austria. BMC Public Health (2014) 0.88
Insulin receptor isoform switching in intestinal stem cells, progenitors, differentiated lineages and tumors: evidence that IR-B limits proliferation. J Cell Sci (2013) 0.87
Circadian rhythms, Wnt/beta-catenin pathway and PPAR alpha/gamma profiles in diseases with primary or secondary cardiac dysfunction. Front Physiol (2014) 0.85
Increased risk of colon cancer in men in the pre-diabetes phase. PLoS One (2013) 0.85
Type 2 diabetes mellitus is associated with increased mortality in Chinese patients receiving curative surgery for colon cancer. Oncologist (2014) 0.85
Increased risk of colorectal cancer in type 2 diabetes is independent of diet quality. PLoS One (2013) 0.85
Diabetes mellitus and poorer prognosis in hepatocellular carcinoma: a systematic review and meta-analysis. PLoS One (2014) 0.85
Impact of high glucose on metastasis of colon cancer cells. World J Gastroenterol (2015) 0.84
Exploring opportunities for colorectal cancer screening and prevention in the context of diabetes self-management: an analysis of the 2010 National Health Interview Survey. Transl Behav Med (2013) 0.84
A retrospective study on the role of diabetes and metformin in colorectal cancer disease survival. Curr Oncol (2016) 0.83
Association between appendectomy and subsequent colorectal cancer development: an Asian population study. PLoS One (2015) 0.83
Diabetes mellitus increases risk for colorectal adenomas in younger patients. World J Gastroenterol (2014) 0.82
Barriers and facilitators to colorectal cancer screening in Vietnamese Americans: a qualitative analysis. J Cancer Educ (2014) 0.82
Homocysteine, methylenetetrahydrofolate reductase C677T polymorphism, and risk of retinal vein occlusion: an updated meta-analysis. BMC Ophthalmol (2014) 0.81
3'-UTR Polymorphisms in the MiRNA Machinery Genes DROSHA, DICER1, RAN, and XPO5 Are Associated with Colorectal Cancer Risk in a Korean Population. PLoS One (2015) 0.80
EphB6 overexpression and Apc mutation together promote colorectal cancer. Oncotarget (2016) 0.79
The morbidity and associated risk factors of cancer in chronic liver disease patients with diabetes mellitus: a multicenter field survey. J Gastroenterol (2014) 0.79
The Effect of Race/Ethnicity on the Age of Colon Cancer Diagnosis. J Health Dispar Res Pract (2013) 0.78
A Risk Prediction Model for Sporadic CRC Based on Routine Lab Results. Dig Dis Sci (2016) 0.78
How significant is the association between metabolic syndrome and prevalence of colorectal neoplasia? World J Gastroenterol (2016) 0.78
Association between factors associated with colorectal cancer and rectal aberrant crypt foci in humans. Oncol Lett (2015) 0.78
Enhanced development of azoxymethane-induced colonic preneoplastic lesions in hypertensive rats. Int J Mol Sci (2013) 0.77
The Activation of ERK1/2 and JNK MAPK Signaling by Insulin/IGF-1 Is Responsible for the Development of Colon Cancer with Type 2 Diabetes Mellitus. PLoS One (2016) 0.77
Association of diabetes and cancer mortality in American Indians: the Strong Heart Study. Cancer Causes Control (2015) 0.76
The Association of Ursodeoxycholic Acid Use With Colorectal Cancer Risk: A Nationwide Cohort Study. Medicine (Baltimore) (2016) 0.76
Primary and secondary prevention of colorectal cancer in the Czech Republic. Prz Gastroenterol (2016) 0.76
Diabetes-induced mechanophysiological changes in the small intestine and colon. World J Diabetes (2017) 0.76
Therapeutic dosages of aspirin counteract the IL-6 induced pro-tumorigenic effects by slowing down the ribosome biogenesis rate. Oncotarget (2016) 0.75
Spatial modelling of type II diabetes outcomes: a systematic review of approaches used. R Soc Open Sci (2015) 0.75
Rectal cancer: a review. Med J Islam Repub Iran (2015) 0.75
Effect of metabolic syndrome and its components on survival in colorectal cancer: a prospective study. J Renal Inj Prev (2015) 0.75
Insulin signaling regulates a functional interaction between Adenomatous Polyposis Coli (APC) and cytoplasmic dynein. Mol Biol Cell (2017) 0.75
Impact of glycemic control on colonoscopy outcomes: bowel preparation and polyp detection. Ann Gastroenterol (2016) 0.75
Prognostic value of glycated hemoglobin in colorectal cancer. World J Gastroenterol (2016) 0.75
Fetal growth and subsequent maternal risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev (2015) 0.75
An Elevated HbA1c Level Is Associated With Short-Term Adverse Outcomes in Patients With Gastrointestinal Cancer and Type 2 Diabetes Mellitus. J Clin Med Res (2017) 0.75
Type 2 diabetes mellitus and colorectal neoplasia risk in Hispanics: a case-control study. J Diabetes Complications (2015) 0.75
Type 2 Diabetes, Antidiabetic Medications, and Colorectal Cancer Risk: Two Case-Control Studies from Italy and Spain. Front Oncol (2016) 0.75
Effect of fusion following decompression for lumbar spinal stenosis: a meta-analysis and systematic review. Int J Clin Exp Med (2015) 0.75
Vitamin D Deficiency Adds an Element of Risk to Insulin Resistance in Colorectal Neoplasms. Dig Dis Sci (2015) 0.75
Structural Change in Microbiota by a Probiotic Cocktail Enhances the Gut Barrier and Reduces Cancer via TLR2 Signaling in a Rat Model of Colon Cancer. Dig Dis Sci (2016) 0.75
Association between metformin and the risk of gastric cancer in patients with type 2 diabetes mellitus: a meta-analysis of cohort studies. Oncotarget (2017) 0.75
Insulin resistance in vascular endothelial cells promotes intestinal tumour formation. Oncogene (2017) 0.75
A novel aromatic mutagen, 5-amino-6-hydroxy-8H-benzo[6,7]azepino[5,4,3-de]quinolin-7-one (ABAQ), induces colonic preneoplastic lesions in mice. Toxicol Rep (2014) 0.75
Meta-analysis in clinical trials. Control Clin Trials (1986) 144.91
Bias in meta-analysis detected by a simple, graphical test. BMJ (1997) 122.24
Quantifying heterogeneity in a meta-analysis. Stat Med (2002) 83.16
Operating characteristics of a rank correlation test for publication bias. Biometrics (1994) 47.97
American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]. Am J Gastroenterol (2009) 12.16
Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet (2004) 8.77
Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. JAMA (2007) 7.79
Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003. Ann Intern Med (2008) 7.71
What is "quality of evidence" and why is it important to clinicians? BMJ (2008) 6.99
Fasting serum glucose level and cancer risk in Korean men and women. JAMA (2005) 6.69
Prevalence of nonpolypoid (flat and depressed) colorectal neoplasms in asymptomatic and symptomatic adults. JAMA (2008) 5.94
Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst (2005) 5.32
Insulin, insulin-like growth factors and colon cancer: a review of the evidence. J Nutr (2001) 5.16
Diabetes and cancer. Endocr Relat Cancer (2009) 5.04
Diagnosis and classification of diabetes mellitus. Diabetes Care (2005) 4.47
Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location. Ann Intern Med (1990) 4.23
Dietary patterns and risk for type 2 diabetes mellitus in U.S. men. Ann Intern Med (2002) 4.19
Publication bias in meta-analysis: its causes and consequences. J Clin Epidemiol (2000) 3.70
Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst (1997) 3.57
Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. J Natl Cancer Inst (2000) 3.57
Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients. Gastroenterology (2004) 3.57
Insulin and colon cancer. Cancer Causes Control (1995) 3.48
Insulin, insulin-like growth factor-I (IGF-I), IGF binding proteins, their biologic interactions, and colorectal cancer. J Natl Cancer Inst (2002) 3.32
Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women. J Natl Cancer Inst (1999) 3.22
Smoking and colorectal cancer: a meta-analysis. JAMA (2008) 3.19
Alcohol intake and colorectal cancer: a pooled analysis of 8 cohort studies. Ann Intern Med (2004) 3.18
Obesity and risk of colorectal cancer: a meta-analysis of 31 studies with 70,000 events. Cancer Epidemiol Biomarkers Prev (2007) 3.16
Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Arch Intern Med (2006) 2.84
Diabetes mellitus and subsite-specific colorectal cancer risks in the Iowa Women's Health Study. Cancer Epidemiol Biomarkers Prev (2005) 2.82
The impact of dietary and lifestyle risk factors on risk of colorectal cancer: a quantitative overview of the epidemiological evidence. Int J Cancer (2009) 2.81
Epidemiology of diabetes and diabetes-related complications. Phys Ther (2008) 2.75
Cigarette smoking and colorectal cancer incidence and mortality: systematic review and meta-analysis. Int J Cancer (2009) 2.67
Bile acids as carcinogens in human gastrointestinal cancers. Mutat Res (2005) 2.64
Clustering of risk behaviors with cigarette consumption: A population-based survey. Prev Med (2006) 2.61
Increased blood glucose and insulin, body size, and incident colorectal cancer. J Natl Cancer Inst (1999) 2.40
Clinically confirmed type 2 diabetes mellitus and colorectal cancer risk: a population-based, retrospective cohort study. Am J Gastroenterol (2006) 2.38
Insulin-like growth factors and cancer. Ann Intern Med (1995) 2.29
Diabetes mellitus and risk of colorectal cancer in the Singapore Chinese Health Study. J Natl Cancer Inst (2006) 2.18
Colorectal cancer risk, chronic illnesses, operations and medications: case control results from the Melbourne Colorectal Cancer Study. 1988. Int J Epidemiol (2007) 2.14
Cancer in inflammatory bowel disease. World J Gastroenterol (2008) 2.12
Two colons-two cancers: paradigm shift and clinical implications. J Surg Oncol (2004) 2.09
Nonpolypoid neoplastic lesions of the colorectal mucosa. Gastrointest Endosc (2008) 2.09
Associations of sedentary lifestyle, obesity, smoking, alcohol use, and diabetes with the risk of colorectal cancer. Cancer Res (1997) 2.06
Colorectal cancer: another complication of diabetes mellitus? Am J Epidemiol (1998) 1.94
Clinicopathological differences between colonic and rectal carcinomas: are they based on the same mechanism of carcinogenesis? Gut (1999) 1.84
Small "flat adenoma" of the large bowel with special reference to its clinicopathologic features. Dis Colon Rectum (1985) 1.82
Meta-analysis of coffee consumption and risk of colorectal cancer. Am J Epidemiol (1998) 1.82
Prospective study of colorectal cancer risk and physical activity, diabetes, blood glucose and BMI: exploring the hyperinsulinaemia hypothesis. Br J Cancer (2001) 1.81
Cancer incidence in patients with type 1 diabetes mellitus: a population-based cohort study in Sweden. J Natl Cancer Inst (2003) 1.79
Physical activity, sedentary behavior, and the risk of colon and rectal cancer in the NIH-AARP Diet and Health Study. Cancer Causes Control (2008) 1.76
Different mechanisms in the tumorigenesis of proximal and distal colon cancers. Curr Opin Oncol (2001) 1.74
The prevalence of colonic polyps in acromegaly: a colonoscopic and pathological study in 103 patients. J Clin Endocrinol Metab (1995) 1.68
Diabetes mellitus and risk of large bowel cancer. J Natl Cancer Inst (1997) 1.68
Diabetes mellitus and cancer risk in a population-based case-control study among men from Montreal, Canada. Int J Cancer (2006) 1.58
Insulin-like growth factor-I and insulin are associated with the presence and advancement of adenomatous polyps. Gastroenterology (2005) 1.58
Preliminary communication: glycated hemoglobin, diabetes, and incident colorectal cancer in men and women: a prospective analysis from the European prospective investigation into cancer-Norfolk study. Cancer Epidemiol Biomarkers Prev (2004) 1.56
Cancer incidence in the National Health and Nutrition Survey I. Follow-up data: diabetes, cholesterol, pulse and physical activity. Cancer Epidemiol Biomarkers Prev (1995) 1.41
Diabetes and cancer risk for all and specific sites among Japanese men and women. Eur J Cancer Prev (2007) 1.30
Aberrant methylation of p16INK4a in anatomic and gender-specific subtypes of sporadic colorectal cancer. Cancer Epidemiol Biomarkers Prev (1999) 1.29
Barrett's oesophagus and colonic tumours. Lancet (1985) 1.28
Fruit and vegetable intakes and risk of colorectal cancer in the NIH-AARP diet and health study. Am J Epidemiol (2007) 1.22
Diabetes and colorectal cancer incidence in the cohort of Swedish men. Diabetes Care (2005) 1.21
Insulin therapy and colorectal adenoma risk among patients with Type 2 diabetes mellitus: a case-control study in Korea. Dis Colon Rectum (2008) 1.20
Metabolic abnormalities and risk for colorectal cancer in the physicians' health study. Cancer Epidemiol Biomarkers Prev (2006) 1.20
A prospective study of anthropometric and clinical measurements associated with insulin resistance syndrome and colorectal cancer in male smokers. Am J Epidemiol (2006) 1.20
Dietary intakes of fruit, vegetables, and fiber, and risk of colorectal cancer in a prospective cohort of women (United States). Cancer Causes Control (2005) 1.18
Colorectal cancer outcomes, recurrence, and complications in persons with and without diabetes mellitus: a systematic review and meta-analysis. Dig Dis Sci (2010) 1.17
Smoking, obesity, and their co-occurrence in the United States: cross sectional analysis. BMJ (2006) 1.16
Decreased efficacy of polyethylene glycol lavage solution (golytely) in the preparation of diabetic patients for outpatient colonoscopy: a prospective and blinded study. Am J Gastroenterol (2001) 1.15
Diabetes mellitus and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev (1997) 1.14
Type 2 diabetes mellitus and the risk of colorectal cancer. Clin Gastroenterol Hepatol (2005) 1.12
Cholecystectomy as a risk factor for colorectal cancer: a meta-analysis. Scand J Gastroenterol (1996) 1.11
The association between diabetes, insulin use, and colorectal cancer among Whites and African Americans. Cancer Epidemiol Biomarkers Prev (2009) 1.10
Loss of heterozygosity on long arm of chromosome 22 in sporadic colorectal carcinoma. World J Gastroenterol (2002) 1.07
Dukes B colorectal cancer: distinct genetic categories and clinical outcome based on proximal or distal tumor location. Dis Colon Rectum (2001) 1.06
Radiation-induced cancers of the colon and rectum: assessing the risk. Gastroenterology (1983) 1.04
Superficial-type adenomas and adenocarcinomas of the colon and rectum: a comparative morphological study. Gastroenterology (1994) 0.96
Diabetes mellitus, family history, and colorectal cancer. J Epidemiol Community Health (2002) 0.90
From obesity to diabetes. Int J Vitam Nutr Res (2006) 0.90
Acquired risk factors for colorectal cancer. Methods Mol Biol (2009) 0.88
Comparison of the diagnostic criteria for diabetes mellitus, WHO-1985, ADA-1997 and WHO-1999 in the adult population of Asturias (Spain). Diabet Med (2003) 0.85
Colon carcinoma and diabetes mellitus. Cancer (1984) 0.84
The effect of autonomous neuropathy on bowel preparation in type 2 diabetes mellitus. Int J Colorectal Dis (2009) 0.81
Modulation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced mutation in the cecum and colon of big blue rats by conjugated linoleic acid and 1,2-dithiole-3-thione. Nutr Cancer (2001) 0.81
[Is cholecystectomy a risk factor for colorectal cancer? A meta-analysis]. Langenbecks Arch Chir (1993) 0.81
Rectosigmoid tumours: should we continue sitting on the fence? Colorectal Dis (2007) 0.79
Sigmoid adenocarcinoma complicating ureterosigmoidostomy. Pediatr Surg Int (1998) 0.79
Mutations induced by 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine (PhIP) in cecum and proximal and distal colon of lacI transgenic rats. Mutagenesis (2001) 0.78
Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency. JAMA (2013) 4.67
Increased mortality from lung cancer and bronchiectasis in young adults after exposure to arsenic in utero and in early childhood. Environ Health Perspect (2006) 4.04
Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium. Cancer (2008) 3.98
Abdominal obesity and body mass index as risk factors for Barrett's esophagus. Gastroenterology (2007) 3.94
Surveillance and survival in Barrett's adenocarcinomas: a population-based study. Gastroenterology (2002) 3.28
A road map for efficient and reliable human genome epidemiology. Nat Genet (2006) 3.21
Fifty-year study of lung and bladder cancer mortality in Chile related to arsenic in drinking water. J Natl Cancer Inst (2007) 3.15
Pregnancy outcomes in women with inflammatory bowel disease: a large community-based study from Northern California. Gastroenterology (2007) 2.76
Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology (2012) 2.68
Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev (2006) 2.59
Control selection strategies in case-control studies of childhood diseases. Am J Epidemiol (2004) 2.55
Elevated lung cancer in younger adults and low concentrations of arsenic in water. Am J Epidemiol (2014) 2.41
Acute myocardial infarction mortality in comparison with lung and bladder cancer mortality in arsenic-exposed region II of Chile from 1950 to 2000. Am J Epidemiol (2007) 2.36
Helicobacter pylori infection and the risk of development of esophageal adenocarcinoma. J Infect Dis (2005) 2.28
Screening colonoscopy and risk for incident late-stage colorectal cancer diagnosis in average-risk adults: a nested case-control study. Ann Intern Med (2013) 2.15
Prevention of vertical transmission of hepatitis B: an observational study. Ann Intern Med (2014) 2.05
A meta-analysis of the association between day-care attendance and childhood acute lymphoblastic leukaemia. Int J Epidemiol (2010) 1.95
Chronic kidney disease and risk of renal cell carcinoma: differences by race. Epidemiology (2015) 1.78
Bronchiectasis in persons with skin lesions resulting from arsenic in drinking water. Epidemiology (2005) 1.72
Marked multi-ethnic variation of esophageal and gastric cardia carcinomas within the United States. Am J Gastroenterol (2004) 1.72
In utero origin of t(8;21) AML1-ETO translocations in childhood acute myeloid leukemia. Blood (2002) 1.71
Parental smoking and the risk of childhood leukemia. Am J Epidemiol (2006) 1.68
Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis. Ann Intern Med (2014) 1.68
A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagus. Nat Genet (2013) 1.67
Case-control study of bladder cancer and exposure to arsenic in Argentina. Am J Epidemiol (2004) 1.67
The emergence of networks in human genome epidemiology: challenges and opportunities. Epidemiology (2007) 1.61
Cigarette smoking and adenocarcinomas of the esophagus and esophagogastric junction: a pooled analysis from the international BEACON consortium. J Natl Cancer Inst (2010) 1.60
A combination of esomeprazole and aspirin reduces tissue concentrations of prostaglandin E(2) in patients with Barrett's esophagus. Gastroenterology (2012) 1.58
Decreased urinary beta-defensin-1 expression as a biomarker of response to arsenic. Toxicol Sci (2008) 1.54
The Stretta procedure for the treatment of GERD: 6 and 12 month follow-up of the U.S. open label trial. Gastrointest Endosc (2002) 1.54
Kidney cancer mortality: fifty-year latency patterns related to arsenic exposure. Epidemiology (2010) 1.52
Critical windows of exposure to household pesticides and risk of childhood leukemia. Environ Health Perspect (2002) 1.52
Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett's esophagus. Nat Genet (2012) 1.52
Lung function in adults following in utero and childhood exposure to arsenic in drinking water: preliminary findings. Int Arch Occup Environ Health (2010) 1.52
Cytogenetics of Hispanic and White children with acute lymphoblastic leukemia in California. Cancer Epidemiol Biomarkers Prev (2006) 1.51
Secondhand smoke exposure in adulthood and risk of lung cancer among never smokers: a pooled analysis of two large studies. Int J Cancer (2004) 1.48
Marked regional variation in adenocarcinomas of the esophagus and the gastric cardia in the United States. Cancer (2002) 1.48
The role of BCG in prevention of leprosy: a meta-analysis. Lancet Infect Dis (2006) 1.47
Accuracy of multiplexed Illumina platform-based single-nucleotide polymorphism genotyping compared between genomic and whole genome amplified DNA collected from multiple sources. Cancer Epidemiol Biomarkers Prev (2006) 1.45
The association between exposure to environmental tobacco smoke and breast cancer: a review by the California Environmental Protection Agency. Prev Med (2006) 1.44
Nonsteroidal anti-inflammatory drug use reduces risk of adenocarcinomas of the esophagus and esophagogastric junction in a pooled analysis. Gastroenterology (2011) 1.44
Increased childhood liver cancer mortality and arsenic in drinking water in northern Chile. Cancer Epidemiol Biomarkers Prev (2008) 1.44
Mortality in young adults following in utero and childhood exposure to arsenic in drinking water. Environ Health Perspect (2012) 1.44
Racial and ethnic variations in hepatocellular carcinoma incidence within the United States. Am J Med (2008) 1.38
Invited commentary: use of arsenical skin lesions to predict risk of internal cancer: implications for prevention and future research. Am J Epidemiol (2013) 1.38
Malignant gliomas in 2005: where to GO from here? JAMA (2005) 1.36
Formaldehyde exposure and leukemia: a new meta-analysis and potential mechanisms. Mutat Res (2008) 1.36
Selenium and lung cancer: a quantitative analysis of heterogeneity in the current epidemiological literature. Cancer Epidemiol Biomarkers Prev (2004) 1.33
Ethnic difference in daycare attendance, early infections, and risk of childhood acute lymphoblastic leukemia. Cancer Epidemiol Biomarkers Prev (2005) 1.32
Making prospective registration of observational research a reality. Sci Transl Med (2014) 1.31
Residential exposure to polychlorinated biphenyls and organochlorine pesticides and risk of childhood leukemia. Environ Health Perspect (2009) 1.31
Body mass index in relation to oesophageal and oesophagogastric junction adenocarcinomas: a pooled analysis from the International BEACON Consortium. Int J Epidemiol (2012) 1.30
Cigarette smoking increases risk of Barrett's esophagus: an analysis of the Barrett's and Esophageal Adenocarcinoma Consortium. Gastroenterology (2012) 1.28
Household vacuum cleaners vs. the high-volume surface sampler for collection of carpet dust samples in epidemiologic studies of children. Environ Health (2008) 1.26
Issues of diagnostic review in brain tumor studies: from the Brain Tumor Epidemiology Consortium. Cancer Epidemiol Biomarkers Prev (2008) 1.25
Germline genetic contributions to risk for esophageal adenocarcinoma, Barrett's esophagus, and gastroesophageal reflux. J Natl Cancer Inst (2013) 1.25
Novel childhood ALL susceptibility locus BMI1-PIP4K2A is specifically associated with the hyperdiploid subtype. Blood (2013) 1.25
NQO1 polymorphisms and de novo childhood leukemia: a HuGE review and meta-analysis. Am J Epidemiol (2008) 1.25
Determinants of agricultural pesticide concentrations in carpet dust. Environ Health Perspect (2011) 1.24
The American Society for Gastrointestinal Endoscopy PIVI (Preservation and Incorporation of Valuable Endoscopic Innovations) on imaging in Barrett's Esophagus. Gastrointest Endosc (2012) 1.23
Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med (2014) 1.22
MDR1 gene variants, indoor insecticide exposure, and the risk of childhood acute lymphoblastic leukemia. Cancer Epidemiol Biomarkers Prev (2007) 1.21
Reproductive and developmental toxicity of formaldehyde: a systematic review. Mutat Res (2011) 1.20
Alcohol types and sociodemographic characteristics as risk factors for Barrett's esophagus. Gastroenterology (2008) 1.19
Alcohol intake and risk of oesophageal adenocarcinoma: a pooled analysis from the BEACON Consortium. Gut (2011) 1.18
Creatinine, diet, micronutrients, and arsenic methylation in West Bengal, India. Environ Health Perspect (2011) 1.18
Factors associated with residential mobility in children with leukemia: implications for assigning exposures. Ann Epidemiol (2009) 1.18
Survival differences by race/ethnicity and treatment for localized hepatocellular carcinoma within the United States. Dig Dis Sci (2009) 1.17
Site-specific translocation and evidence of postnatal origin of the t(1;19) E2A-PBX1 fusion in childhood acute lymphoblastic leukemia. Proc Natl Acad Sci U S A (2002) 1.16
Household exposure to paint and petroleum solvents, chromosomal translocations, and the risk of childhood leukemia. Environ Health Perspect (2008) 1.13
Breastfeeding and the risk of childhood leukemia: a meta-analysis. Public Health Rep (2004) 1.13
Burden of disease, health indicators and challenges for epidemiology in North America. Int J Epidemiol (2012) 1.12
Current perspective on the global and United States cancer burden attributable to lifestyle and environmental risk factors. Annu Rev Public Health (2013) 1.10
Fecal Immunochemical Test Program Performance Over 4 Rounds of Annual Screening: A Retrospective Cohort Study. Ann Intern Med (2016) 1.10
The Childhood Leukemia International Consortium. Cancer Epidemiol (2013) 1.09
Maternal pregnancy loss, birth characteristics, and childhood leukemia (United States). Cancer Causes Control (2005) 1.07
Maternal illness and drug/medication use during the period surrounding pregnancy and risk of childhood leukemia among offspring. Am J Epidemiol (2006) 1.07
Dietary factors and the risks of oesophageal adenocarcinoma and Barrett's oesophagus. Nutr Res Rev (2010) 1.05
Dietary antioxidants, fruits, and vegetables and the risk of Barrett's esophagus. Am J Gastroenterol (2008) 1.04
Serum ghrelin levels and risk of subsequent adenocarcinoma of the esophagus. Am J Gastroenterol (2007) 1.04
Molecular biomarkers for the study of childhood leukemia. Toxicol Appl Pharmacol (2005) 1.04
Chronic respiratory symptoms in children following in utero and early life exposure to arsenic in drinking water in Bangladesh. Int J Epidemiol (2013) 1.03
Dietary patterns and the risk of Barrett's esophagus. Am J Epidemiol (2008) 1.03
Meta-analysis of antioxidant intake and the risk of esophageal and gastric cardia adenocarcinoma. Am J Gastroenterol (2007) 1.03
Evidence from Chile that arsenic in drinking water may increase mortality from pulmonary tuberculosis. Am J Epidemiol (2010) 1.03
Reproductive and sex hormonal factors and oesophageal and gastric junction adenocarcinoma: a pooled analysis. Eur J Cancer (2010) 1.03
Arsenic, tobacco smoke, and occupation: associations of multiple agents with lung and bladder cancer. Epidemiology (2013) 1.02
Oral pre-exposure prophylaxis (PrEP) for prevention of HIV in serodiscordant heterosexual couples in the United States: opportunities and challenges. AIDS Patient Care STDS (2014) 1.02
Hypermethylation of the 5' CpG island of the FHIT gene is associated with hyperdiploid and translocation-negative subtypes of pediatric leukemia. Cancer Res (2004) 1.02
Polybrominated diphenyl ethers in residential dust: sources of variability. Environ Int (2013) 1.01
Food consumption by children and the risk of childhood acute leukemia. Am J Epidemiol (2004) 1.01
Genetic variants in the folate pathway and risk of childhood acute lymphoblastic leukemia. Cancer Causes Control (2011) 1.00
Personal use of hair dyes and risk of bladder cancer: a meta-analysis of epidemiologic data. Cancer Causes Control (2008) 0.99
Case-control study of arsenic in drinking water and kidney cancer in uniquely exposed Northern Chile. Am J Epidemiol (2013) 0.98
Residential levels of polybrominated diphenyl ethers and risk of childhood acute lymphoblastic leukemia in California. Environ Health Perspect (2014) 0.98
Genetic variants in ARID5B and CEBPE are childhood ALL susceptibility loci in Hispanics. Cancer Causes Control (2013) 0.97
Cigarette smoking and the risk of Barrett's esophagus. Cancer Causes Control (2008) 0.97
Exposure to herbicides in house dust and risk of childhood acute lymphoblastic leukemia. J Expo Sci Environ Epidemiol (2013) 0.97
Profound deficit of IL10 at birth in children who develop childhood acute lymphoblastic leukemia. Cancer Epidemiol Biomarkers Prev (2011) 0.97